At the news
? NEUTRALIMPACT 3/10 CLUSTER filed May 6, 2026 at 20:00 ET
Two directors at LeMaitre Vascular sold a combined $994K in open-market sales on May 7, 2026, following the company's strong Q1 2026 earnings beat and raised guidance. The sales are modest relative to the $2.5B market cap (0.04%) and are likely routine portfolio rebalancing after a period of strong stock performance, not a bearish signal.
- Two directors sold a total of $994K in open-market sales on May 7, 2026.
- Sales represent 0.04% of LMAT's $2.5B market cap, trivial in size.
- Q1 2026 EPS of $0.68 beat consensus by 3%, revenue of $66.6M was in line.
- Full-year 2026 guidance raised: operating income midpoint to $79.8M, EPS to $3.00.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access